Clinical-stage biopharmaceutical company focused on developing therapies for transthyretin amyloidosis (ATTR), a rare, progressive disorder that affects the nerves, heart and gastrointestinal tract
Eidos Therapeutics
Recent Posts
Recent Comments
No comments to show.